Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/07/1997US5674712 Recombinant vector and use thereof for exocellular preparation of antibodies in single molecule form from Bacillus subtilis
10/07/1997US5674710 Recombinant techniques for production of human brain natriuretic peptide
10/07/1997US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid
10/07/1997US5674704 Polypeptide; human cell surface receptor
10/07/1997US5674692 Methods for diabetes susceptibility assessment in asymptomatic patients
10/07/1997US5674691 Method of screening for ligands to a receptor-type tyrosine kinase
10/07/1997US5674689 Human calcitonin receptor polypeptides and methods of use
10/07/1997US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997US5674537 Electrolyzed saline solution containing concentrated amounts of ozone and chlorine species
10/07/1997US5674534 Composition for sustained release of non-aggregated erythropoietin
10/07/1997US5674532 Solvent extraction, shaping in smaller spherical particles, drying, coating with gastric-juice preventive film; used in human and veterinary medicine
10/07/1997US5674528 Using stroma-free hemoglobin from erythrocytes in solution with glucose and adenine, inosine or adenine triphosphate; enzymatically active; oxygen affinity; resistance to oxidation into methemoglobin; artificial blood
10/07/1997US5674494 Treating non-malignant disease states with IL-2 receptor-specific substances
10/07/1997US5674493 Compositions and methods for targeting cells with A2R and A2R monoclonal antibodies
10/07/1997US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40
10/07/1997US5674489 Inhibiting blood coagulation by administering platelet factor 4
10/07/1997US5674488 Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol
10/07/1997US5674487 Method for treating autoimmune diseases
10/07/1997US5674486 Stimulating immune response against tumor antigen by immunizing with genetic engineered cells
10/07/1997US5674483 Treatment for diseases involving inflammation
10/07/1997US5674394 Single use system for preparation of autologous plasma
10/07/1997US5674205 Device for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
10/07/1997US5674192 Method of gene therapy
10/07/1997CA2041380C Use of protein c or activated protein c for preparing a pharmaceutical preparation
10/02/1997WO1997036005A1 Oligonucleotide treatments and compositions for human melanoma
10/02/1997WO1997035998A1 Methods of modulating melanin synthesis
10/02/1997WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997WO1997035994A2 Cytochrome p450 transducing retroviral vectors
10/02/1997WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997WO1997035990A2 Histone deacetylases, and uses related thereto
10/02/1997WO1997035989A2 Cyclic nucleotide phosphodiesterase
10/02/1997WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997WO1997035979A1 Novel trio molecules and uses related thereto
10/02/1997WO1997035976A2 Epidermal differentiation factor
10/02/1997WO1997035975A1 E2f-like transcription repressor and dna encoding it
10/02/1997WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997WO1997035971A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
10/02/1997WO1997035969A2 Peptide ligands of the urokinase receptor
10/02/1997WO1997035963A1 Novel beta-2 adrenergic receptor subtype and use thereof
10/02/1997WO1997035962A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
10/02/1997WO1997035887A1 Precursors of catalytic antibodies
10/02/1997WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997WO1997035884A1 Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
10/02/1997WO1997035883A1 Method and apparatus for preparing an acellular red blood cell substitute
10/02/1997WO1997035882A1 Lyophilized pulmonary surfactant peptide compositions
10/02/1997WO1997035881A2 Receptor and transporter antagonists
10/02/1997WO1997035880A2 Polynucleic acid sequences that are functionally associated with the development of autoimmune disease
10/02/1997WO1997035877A1 Antibiotic peptides from bovine milk
10/02/1997WO1997035876A1 Compounds which prevent neuronal cell death and uses thereof
10/02/1997WO1997035875A1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
10/02/1997WO1997035873A2 Peptides with antiproliferative properties
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035621A1 Scleral plug containing proteinaceous medicine
10/02/1997WO1997035620A1 Formulations of ob protein
10/02/1997WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997WO1997035616A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
10/02/1997WO1997035615A1 Compositions and methods for inhibiting clot formation
10/02/1997WO1997035614A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997WO1997035609A1 Neovascularization inhibitor containing tissue factor pathway inhibitor
10/02/1997WO1997035608A1 Diabetes treatment
10/02/1997WO1997035607A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
10/02/1997WO1997035606A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders
10/02/1997WO1997035605A1 Manipulation of mitotically active cells of the hippocampal region of the brain
10/02/1997WO1997035604A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
10/02/1997WO1997035603A1 Cyclosporin a formulations as nanoparticles
10/02/1997WO1997035602A1 Use of vasopressin receptor antagonist for regulation of acth release
10/02/1997WO1997035601A1 TREATMENT OF CYSTIC DISEASE WITH TNF-$g(a)
10/02/1997WO1997035600A1 Glycosylated amylins
10/02/1997WO1997035579A1 A method for inhibiting clot formation
10/02/1997WO1997035562A1 Polysaccharide microspheres for the pulmonary delivery of drugs
10/02/1997WO1997035561A1 Materials and methods for making improved liposome compositions
10/02/1997WO1997035560A1 Materials and methods for making improved echogenic liposome compositions
10/02/1997WO1997035477A1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
10/02/1997WO1997029201A3 Retroviral vector for the gene transfer of an il6 antagonist in human haematopoietic stem cells
10/02/1997WO1997028825A3 Spermatogenesis control
10/02/1997WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997WO1997024111A3 Novel hyaluronic acid receptors binding agents and the use thereof
10/02/1997WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997WO1997014797A3 Cystatin m, a novel cysteine proteinase inhibitor
10/02/1997WO1997013502A3 Prolonged release of gm-csf
10/02/1997DE19612967A1 Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren Method for replication of influenza viruses in cell culture, as well as the influenza viruses obtainable by the process
10/02/1997DE19612805A1 Antifungische Peptide aus Scleroderma texense Texense antifungal peptides from Scleroderma
10/02/1997DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997CA2251691A1 Peptides with antiproliferative properties
10/02/1997CA2250923A1 Oligonucleotide treatments and compositions for human melanoma
10/02/1997CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997CA2250570A1 Formulations of ob protein
10/02/1997CA2250567A1 Receptor and transporter antagonists
10/02/1997CA2250403A1 Treatment of cystic disease with tnf-a
10/02/1997CA2250332A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997CA2250207A1 A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
10/02/1997CA2250173A1 Cytochrome p450 transducing retroviral vectors
10/02/1997CA2250166A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997CA2250124A1 Novel trio molecules and uses related thereto
10/02/1997CA2250099A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997CA2250053A1 Polysaccharide microspheres for the pulmonary delivery of drugs
10/02/1997CA2250008A1 Neovascularization inhibitor containing tissue factor pathway inhibitor
10/02/1997CA2249998A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997CA2249455A1 Precursors of catalytic antibodies
10/02/1997CA2249454A1 Diabetes treatment
1 ... 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 ... 3163